Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies
- PMID: 33718206
- PMCID: PMC7952756
- DOI: 10.3389/fonc.2021.629390
Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies
Abstract
With the aging of the population, the incidence of colorectal cancer in China is increasing. One of the epigenetic alterations: CpG island methylator phenotype (CIMP) plays an important role in the incidence of colorectal cancer. Recent studies have shown that CIMP is closely related to some specific clinicopathological phenotypes and multiple molecular phenotypes in colorectal cancer. In this paper, the newest progress of CIMP colorectal cancer in chemotherapeutic drugs, targeted agents and small molecular methylation inhibitors are going to be introduced. We hope to provide potential clinical treatment strategies for personalized and precise treatment of colorectal cancer patients.
Keywords: CpG island methylator phenotype; DNA methylation inhibitor; chemotherapy; colorectal cancer; targeted therapy.
Copyright © 2021 Zhang, Zhang and Cao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25. Hum Pathol. 2016. PMID: 26520418
-
Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.Histol Histopathol. 2013 May;28(5):585-95. doi: 10.14670/HH-28.585. Epub 2013 Jan 23. Histol Histopathol. 2013. PMID: 23341177 Review.
-
CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.Int J Clin Oncol. 2016 Dec;21(6):1091-1101. doi: 10.1007/s10147-016-1017-6. Epub 2016 Jul 19. Int J Clin Oncol. 2016. PMID: 27435270
-
The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158. Mol Cancer Res. 2008. PMID: 18403637
-
Biological significance of the CpG island methylator phenotype.Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):35-42. doi: 10.1016/j.bbrc.2014.07.007. Epub 2014 Jul 10. Biochem Biophys Res Commun. 2014. PMID: 25016183 Review.
Cited by
-
Hypermethylated Colorectal Cancer Tumours Present a Myc-Driven Hypermetabolism with a One-Carbon Signature Associated with Worsen Prognosis.Biomedicines. 2024 Mar 6;12(3):590. doi: 10.3390/biomedicines12030590. Biomedicines. 2024. PMID: 38540202 Free PMC article.
-
Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance.Int J Mol Sci. 2024 Nov 21;25(23):12507. doi: 10.3390/ijms252312507. Int J Mol Sci. 2024. PMID: 39684219 Free PMC article. Review.
-
Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know.Radiol Imaging Cancer. 2023 Nov;5(6):e220153. doi: 10.1148/rycan.220153. Radiol Imaging Cancer. 2023. PMID: 37921555 Free PMC article. Review.
-
Research progress on the diagnostic value of fecal calprotectin in colorectal tumors.Front Med (Lausanne). 2025 Jul 9;12:1626197. doi: 10.3389/fmed.2025.1626197. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40703287 Free PMC article. Review.
-
Emerging roles of cystathionine β-synthase in various forms of cancer.Redox Biol. 2022 Jul;53:102331. doi: 10.1016/j.redox.2022.102331. Epub 2022 May 10. Redox Biol. 2022. PMID: 35618601 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources